Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

Details for Australian Patent Application No. 2009237579 (hide)

Owner Reata Pharmaceuticals, Inc.

Inventors Anderson, Eric; Visnick, Melean; Jiang, Xin

Agent Pizzeys

Pub. Number AU-A-2009237579

PCT Pub. Number WO2009/129546

Priority 61/046,342 18.04.08 US; 61/111,269 04.11.08 US

Filing date 20 April 2009

Wipo publication date 22 October 2009

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07J 63/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/129546 Priority application(s): WO2009/129546

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237581-Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

2009237578-Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring